CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Shares withheld for taxes Chairman and CEO gave up 3,558 shares (to pay taxes)
- 4 Shares withheld for taxes VP Chief Financial Officer gave up 5,930 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4/A Grant or award Director acquired 2,500 shares (grant or award)
- 4/A Grant or award Director acquired 2,500 shares (grant or award)
- 4/A Grant or award Director acquired 2,500 shares (grant or award)
- 4/A Grant or award Director acquired 6,500 shares (grant or award)
- 4/A Grant or award Director acquired 2,500 shares (grant or award)
- 4 Open-market buy Director bought 154 shares at an average $1.66 ($256)
- 4 Open-market buy Director bought 769 shares at an average $1.71 ($1,318)
- 4 Open-market buy Chairman and CEO bought 769 shares at an average $1.71 ($1,318)
Page 6 of 52 · 1,039 filings